COMPANY INFO
In-House Health is the actual company name. It was founded in 2023 by Ari Brenner, Sergey Vasilenko, and Shachar Har Zvi. The company has around 29 to 39 employees and is headquartered in New York City. Its website is https://www.inhouse.health/. In-House Health operates in the Hospitals and Health Care industry, providing an AI-driven scheduling and management platform for modern nursing teams. The company aims to restore sustainability to nursing by offering transformative technology that enables nursing workforces within care delivery systems to effectively structure themselves and meet rising demands, making bedside nursing a career of choice again. It offers a predictive scheduling platform that personalizes shifts to patient needs by automating scheduling workflows using machine learning from past cases.
In-House Health is a health technology company founded in 2023 by Ari Brenner, Sergey Vasilenko, and Shachar Har Zvi. Headquartered in New York City with additional offices in Denver and Tel Aviv, the company operates in the Hospitals and Health Care industry. In-House Health provides an AI-driven scheduling and management platform designed for modern nursing teams. Its mission is to restore sustainability to nursing by enabling care delivery systems to better structure their workforces, meet rising healthcare demands, and make bedside nursing an attractive, sustainable career choice. The platform leverages machine learning and past-case data to personalize shifts and automate complex scheduling workflows, improving both nurse and patient outcomes.
In-House Health funding history reflects a focused and strategic approach. To date, the company has raised $5.4 million across one funding round, with the seed round in 2024 marking a significant milestone. This funding enables the development and launch of In-House Health’s AI-powered scheduling platform, targeting the critical challenge of nurse shortages and efficiency in hospital staffing. The investment strategy centers on leveraging reputable venture capital firms to propel product development and market entry in the competitive health tech landscape. By securing support from both leading VCs and industry-focused partners, In-House Health is strategically positioned to scale its technology and impact the future of nursing.
This seed funding round was led by New Enterprise Associates (NEA) and TMV, with participation from Vine Ventures and Longevity Venture Partners. The capital is being used to accelerate the development and deployment of In-House Health’s AI-driven platform, tackling the nationwide nurse shortage and transforming hospital staffing efficiency.
No earlier rounds reported.
NEA is one of the world’s largest venture capital firms, backing innovative technology and healthcare startups. As the lead investor in In-House Health’s seed round, NEA brings deep expertise in healthcare venture capital and strategic guidance.
TMV is a venture capital firm that invests in mission-driven companies solving systemic problems. As a co-lead investor, TMV supports In-House Health with capital and operational expertise, helping accelerate growth and product scalability.
Vine Ventures is an early-stage venture capital firm with a portfolio of disruptive tech startups. Vine Ventures participated in the seed round and provides ongoing advisory and network support to foster In-House Health’s investment success.
Longevity Venture Partners is an investor focused on companies extending and improving human health. Their participation in the seed round demonstrates confidence in In-House Health’s mission and technology.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching In-House Health funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.